Skip to content

Detection of Enterovirus Genotypes by CRISPR Technology

Rapid Identification and Clinical Transformation of Various Enterovirus Genotypes Based on CRISPR Technology

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04535648
Enrollment
0
Registered
2020-09-02
Start date
2023-04-30
Completion date
2024-09-30
Last updated
2023-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enterovirus Infections

Brief summary

CRISPR-enterovirus detection system was constructed in this study for detection variety genotypes of enterovirus rapidly in children suspected or diagnosed as enterovirus infection.

Detailed description

To construct CRISPR-enterovirus detection system, we screened the targets, primers and CrRNA and evaluated the capability of this detecting system. Samples of feces, blood and cerebrospinal fluid (the remainder of routine testing samples) from 500 children with suspected or confirmed enterovirus infection were examined using the CRISPR technique. To evaluate the CRISPR-enterovirus detection system, real-time PCR and traditional PCR as comparison method was implemented. The method of real-time PCR and traditional PCR were used to detect enterovirus and analyze the genotypes of enterovirus, respectively. According to the results of CRISPR-enterovirus detection system and the comparison method, the positive coincidence rate, negative coincidence rate and consistency of the two methods were calculated. Furthermore, the sensitivity and specificity of the CRISPR-enterovirus detection system for detection of enterovirus were calculated.

Interventions

OTHERNon-invasive detection method: CRISPR techonology

This study was a laboratory diagnostic study without any intervention.

Sponsors

Children's Hospital of Fudan University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
1 Days to 18 Years
Healthy volunteers
No

Inclusion criteria

* Patients with clinically suspected or confirmed enterovirus infection

Exclusion criteria

* Patients with clinical diagnosis of non-enterovirus infection

Design outcomes

Primary

MeasureTime frameDescription
Successful construction of CRISPR-enterovirus detection systemAt enrollmentIt is a binary variable (yes/no).If the system meet all the following criteria, it would be setted into yes .According to the results of CRISPR-enterovirus detection system and the comparison method: 1. the positive coincidence rate and negative coincidence rate are both over 95.0%; 2. the value of Kappa using to express the consistency of those two methods is over 0.75; 3. the sensitivity and specificity of the CRISPR-enterovirus detection system for detection of enterovirus are over 90.0% and 95.0%; 4. the coefficient of variation between batches is less 15.0%, and each batch detection takes less than 1 hour.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026